RxDoctor Payments Data

Kristen Rezak, MD

Plastic and Reconstructive Surgery · Raleigh, NCNPI 1801086905

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.9% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 42.6% of the total.

$5,292in general payments, 2019–2025

Across 69 payments — averaging $76.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Mentor Worldwide LLC$871
  • Motiva USA, LLC$433
  • Musculoskeletal Transplant Foundation Inc.$300
  • Dilon Technologies, Inc.$278
  • Vioptix Inc$262
  • plus $894 from 8 others

What the payments were for

  • Food & beverage$5,12797%
  • Entertainment$1663%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,292 in reported general payments places this provider in the 60th percentile of 55 plastic and reconstructive surgery providers in North Carolina.

See all plastic and reconstructive surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$12,698
Medicare patients
21
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →